To contact members of the team please email firstname.lastname@example.org
Chief Editor: Lin Lee, DPhil
Lin joined BMC Medicine in late 2010 starting as Assistant Editor, having previously completed a DPhil at the University of Oxford using fruit flies to model the neurodegenerative disease Spinal Muscular Atrophy. She has interests in global health and policy, and non-communicable diseases.
Senior Editor: Alessandro Recchioni
Alessandro graduated in BSc Biochemistry from University College London, completing a research project on the investigation of archaeal antitermination complexes before joining BMC Medicine in 2013. His current main areas of interest in the journal are Gastroenterology, Hepatology and Cardiology, and he is based in the Berlin office.
Senior Editor: Marie-Elizabeth Barabas, PhD
Marie-Elizabeth completed a PhD in the Department of Cell Biology, Neurobiology and Anatomy at the Medical College of Wisconsin, studying the roles of TRPA1 and TRPV1 in dorsal root ganglion neurons on pain transduction. This was followed by a postdoc based at St. Jude Children’s Research Hospital, helping to optimize a protocol to reprogram mature murine retinal neurons into iPSCs and then differentiate the retinal-derived iPSCs into 3D retinal tissue in vitro. In 2016, Marie relocated to New York to pursue a career in publishing. Her interests include neurology, neuroscience, medical imaging, pharmacology, regenerative and personalized medicine. She is based in the New York office.
Associate Editor: Eva Szunyogova, PhD
Eva completed her Undergraduate Degree in Biomedical Sciences at the University of Aberdeen. After graduating, Eva stayed on at the university to complete her PhD in Translational Neuroscience where she focussed on therapies for Spinal Muscular Atrophy, a leading inherited cause of infant mortality. In 2017, Eva relocated to London to pursue a career in publishing, and to develop her interest in science communication. Her particular interests are in Cancer research, Infectious diseases, and Global health. She is based in the London office.
Announcement: COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
- Editorial Team
- Editorial Board
- Call for papers
- Sign up for article alerts and news from this journal
In response to the current outbreak of novel coronavirus, SARS-CoV-2, BMC Medicine editors will treat relevant submissions with priority.
BMC Medicine is accepting Registered Reports. Find out more about this innovative format in our Submission Guidelines.